APOE and Alzheimer disease: Regarding potential limitations of the study, investigating the effect of N‐PRS on the conversion of aMCI to AD, besides controlling for age, gender, and APOE ε4, requires consideration of other risk factors that influence AD progression, such as whether the patient has other comorbid neuropsychiatric diseases.